Glycans in Vaccine Development

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Screening and drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Related Conference of Glycans in Vaccine Development

September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018 |

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 11-12, 2018

13th International Conference on Metabolomics and Systems Biology

Hilton Zurich Airport Hohenbuehlstrasse 10, 8152, Opfikon, Switzerland
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Paris, France
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany
July 31-August 01, 2019

6th International Conference on Glycobiology & Glycoproteomics

Chicago, Illinois, USA

Glycans in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in